Clinical Trial Update: Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS [NA]

View source ↗

Summary

A completed trial evaluating peri-transfusion quality-of-life assessments to support transfusion decisions in myelodysplastic syndromes. The study results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Myelodysplastic Syndromes | NA | Status: COMPLETED | Results posted: 2024-06-21